Author Archive: Jim Greenwood

Jim Greenwood

Jim joined BIO as President & CEO in 2005 after representing the eighth district of Pennsylvania in the U.S. House of Representatives for six terms.  He had worked with BIO while in Congress on stem cell research and other health issues, and has since learned so much about the many applications of the science in food and agriculture and in industrial and environmental biotechnology.

Due to its revolutionary research and development in issues ranging from feeding the world by increasing crop yields to healing the world with new medicines to providing cleaner sources of energy, Jim is a passionate champion for biotechnology. When visiting member companies, he is inspired by executives and scientists who are united in their mission to help patients, farmers and other consumers lead a better life.

Prior to Congress, Jim served in the Pennsylvania House of Representatives and Pennsylvania Senate for six years each.  He and his wife Tina live in historic Washington Crossing, Pennsylvania (where he has participated in the re-enactment of George Washington crossing the Delaware River on Christmas Day in 1776). He enjoys fishing, birding and scuba diving.

You can find him on Facebook at https://www.facebook.com/jamescgreenwood.

Latest Posts

Meeting India’s Biotech Community

Biotechnology is a global enterprise.  The United States continues to play the dominant role but European and Asian nations are continually expanding their capabilities. In preparation for BIO’s first ever partnering meeting in India in September 2010, I am travelling the subcontinent to promote the event and to assess the country’s biotech capabilities and needs. On November 4th in Mumbai, I visited Reliance Life Sciences which represents a huge investment in biotech from one of Read More >

Jim's Corner  |  Leave a comment  |  Email This Post

Encouraging Louisiana to Partner with BIO

Louisiana is one of just a few states that do not yet have a BIO affiliate. I was invited to speak to community leaders in New Orleans by Jim McNamara, a local real estate investor who is presently the Secretary of the Board of the New Orleans BioInnovation Center, a Member of the Greater New Orleans Biosciences Economic Development District and a Commissioner of the Downtown Development District of New Orleans. Jim believes biotechnology can Read More >

Jim's Corner  |  Leave a comment  |  Email This Post

Protection against Seasonal Flu

Today, BIO offered seasonal flu vaccines to all employees, many of whom joined me in getting one.  While getting vaccinated against seasonal flu is important, it will not protect us from H1N1 flu so we were advised to get vaccinated against that once it is available. BIO member companies have played a major role in the development and distribution of both the seasonal influenza vaccination and the H1N1 vaccination.  Five BIO member companies are at Read More >

Jim's Corner  |  Leave a comment  |  Email This Post

Biotech Advances in South Dakota

Biotech Advances in South Dakota

Last week I made my first visit to our South Dakota affiliate. The South Dakota Biotech Association, formed in 2006, held its fourth annual conference on Thursday, September 17th. I began my tour on Wednesday at Hematech, Inc.   The company, headquartered in Sioux Falls, is developing cattle that can efficiently produce human antibodies.  The genetically altered cattle will be used for the production of large quantities of polyclonal antibodies.  These antibodies are expected to help Read More >

Jim's Corner  |  Leave a comment  |  Email This Post

Touring Local Biotech Companies with Former Governor Dean

Touring Local Biotech Companies with Former Governor Dean

Last week I spent a fascinating day with former Vermont Governor Howard Dean and three Members of the Maryland Congressional delegation.  First, along with local Congressman Roscoe Bartlett (R, MD-6), we visited MedImunne’s brand new biologic manufacturing facility in Frederick. The half billion dollar facility is nearly complete and will employ 350 people manufacturing the company’s monoclonal antibody, Synagis. This product helps prevent lower respiratory disease from a common virus which in vulnerable children, particularly Read More >

Jim's Corner  |  Leave a comment  |  Email This Post